View Item 

Show simple item record

Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository
dc.contributor.authorZuo, Yu
dc.contributor.authorNavaz, Sherwin
dc.contributor.authorTsodikov, Alex
dc.contributor.authorKmetova, Katarina
dc.contributor.authorKluge, Lyndsay
dc.contributor.authorAmbati, Amala
dc.contributor.authorHoy, Claire K.
dc.contributor.authorYalavarthi, Srilakshmi
dc.contributor.authorAndrade, Danieli
dc.contributor.authorTektonidou, Maria G.
dc.contributor.authorSciascia, Savino
dc.contributor.authorPengo, Vittorio
dc.contributor.authorRuiz-Irastorza, Guillermo
dc.contributor.authorBelmont, H. Michael
dc.contributor.authorGerosa, Maria
dc.contributor.authorFortin, Paul R.
dc.contributor.authorJesus, Guilherme Ramires
dc.contributor.authorBranch, D. Ware
dc.contributor.authorAndreoli, Laura
dc.contributor.authorRodriguez-Almaraz, Esther
dc.contributor.authorPetri, Michelle
dc.contributor.authorCervera, Ricard
dc.contributor.authorWillis, Rohan
dc.contributor.authorKarp, David R.
dc.contributor.authorLi, Quan-Zhen
dc.contributor.authorCohen, Hannah
dc.contributor.authorBertolaccini, Maria Laura
dc.contributor.authorErkan, Doruk
dc.contributor.authorKnight, Jason S.
dc.contributor.authorPons-Estel, Guillermo
dc.date.accessioned2023-08-01T18:28:26Z
dc.date.available2024-09-01 14:28:24en
dc.date.available2023-08-01T18:28:26Z
dc.date.issued2023-08
dc.identifier.citationZuo, Yu; Navaz, Sherwin; Tsodikov, Alex; Kmetova, Katarina; Kluge, Lyndsay; Ambati, Amala; Hoy, Claire K.; Yalavarthi, Srilakshmi; Andrade, Danieli; Tektonidou, Maria G.; Sciascia, Savino; Pengo, Vittorio; Ruiz-Irastorza, Guillermo ; Belmont, H. Michael; Gerosa, Maria; Fortin, Paul R.; Jesus, Guilherme Ramires; Branch, D. Ware; Andreoli, Laura; Rodriguez-Almaraz, Esther ; Petri, Michelle; Cervera, Ricard; Willis, Rohan; Karp, David R.; Li, Quan-Zhen ; Cohen, Hannah; Bertolaccini, Maria Laura; Erkan, Doruk; Knight, Jason S.; Pons-Estel, Guillermo (2023). "Anti- Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody- Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository." Arthritis & Rheumatology 75(8): 1407-1414.
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.urihttps://hdl.handle.net/2027.42/177399
dc.publisherWiley Periodicals, Inc.
dc.titleAnti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelRheumatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/177399/1/art42489_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/177399/2/art42489.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/177399/3/art42489-sup-0001-Disclosureform.pdf
dc.identifier.doi10.1002/art.42489
dc.identifier.sourceArthritis & Rheumatology
dc.identifier.citedreferenceTambralli A, Gockman K, Knight JS. NETs in APS: current knowledge and future perspectives. Curr Rheumatol Rep 2020; 22: 67.
dc.identifier.citedreferenceGarcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. N Engl J Med 2018; 378: 2010 – 21.
dc.identifier.citedreferenceYu Y, Su K. Neutrophil extracellular traps and systemic lupus erythematosus. J Clin Cell Immunol 2013; 4.
dc.identifier.citedreferenceGomez-Puerta JA, Martin H, Amigo MC, et al. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Medicine (Baltimore) 2005; 84: 225 – 30.
dc.identifier.citedreferenceChen HH, Lin CH, Chao WC. Risk of systemic lupus erythematosus in patients with anti-phospholipid syndrome: a population-based study. Front Med (Lausanne) 2021; 8: 654791.
dc.identifier.citedreferencePierangeli SS, Colden-Stanfield M, Liu X, et al. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 1999; 99: 1997 – 2002.
dc.identifier.citedreferenceMuller S, Dieker J, Tincani A, et al. Pathogenic anti-nucleosome antibodies. Lupus 2008; 17: 431 – 6.
dc.identifier.citedreferenceMjelle JE, Rekvig OP, Fenton KA. Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis. Ann Rheum Dis 2007; 66: 1661 – 8.
dc.identifier.citedreferenceKramers C, Hylkema MN, van Bruggen MC, et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 1994; 94: 568 – 77.
dc.identifier.citedreferenceXu D, Olson J, Cole JN, et al. Heparan sulfate modulates neutrophil and endothelial function in antibacterial innate immunity. Infect Immun 2015; 83: 3648 – 56.
dc.identifier.citedreferenceMarques C, Reis CA, Vives RR, et al. Heparan sulfate biosynthesis and sulfation profiles as modulators of cancer signalling and progression. Front Oncol 2021; 11: 778752.
dc.identifier.citedreferenceSharp TH, Boyle AL, Diebolder CA, et al. Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b. Proc Natl Acad Sci U S A 2019; 116: 11900 – 5.
dc.identifier.citedreferenceO’Flynn J, Dixon KO, Krol MC, et al. Myeloperoxidase directs properdin-mediated complement activation. J Innate Immun 2014; 6: 417 – 25.
dc.identifier.citedreferenceYuen J, Pluthero FG, Douda DN, et al. NETosing neutrophils activate complement both on their own NETs and bacteria via alternative and non-alternative pathways. Front Immunol 2016; 7: 137.
dc.identifier.citedreferenceChaturvedi S, Brodsky RA, McCrae KR. Complement in the pathophysiology of the antiphospholipid syndrome. Front Immunol 2019; 10: 449.
dc.identifier.citedreferenceLeffler J, Martin M, Gullstrand B, et al. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 2012; 188: 3522 – 31.
dc.identifier.citedreferenceHakkim A, Furnrohr BG, Amann K, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A 2010; 107: 9813 – 8.
dc.identifier.citedreferenceHochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
dc.identifier.citedreferenceZuo Y, Yalavarthi S, Navaz SA, et al. Autoantibodies stabilize neutrophil extracellular traps in COVID-19. JCI Insight 2021; 6.
dc.identifier.citedreferenceAli RA, Gandhi AA, Meng H, et al. Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. Nat Commun 2019; 10: 1916.
dc.identifier.citedreferenceErkan D, Sciascia S, Bertolaccini ML, et al. Antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION): 10-year update. Curr Rheumatol Rep 2021; 23: 45.
dc.identifier.citedreferenceZuo Y, Yalavarthi S, Gockman K, et al. Anti-neutrophil extracellular trap antibodies and impaired neutrophil extracellular trap degradation in antiphospholipid syndrome. Arthritis Rheumatol 2020; 72: 2130 – 5.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
art42489_am.pdf
Size:
332.0KB
Format:
PDF
View/Open
Name:
art42489.pdf
Size:
1.043MB
Format:
PDF
View/Open
Name:
art42489-sup-0001-Disclosurefo ...
Size:
3.976MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.